Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Deep mutational scanning of SARS-CoV-2 spike fusion peptide

PROVIDER: PRJNA910585 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22668006_1.fastq.gz	Fastqsanger.gz
	SRR22668006_2.fastq.gz	Fastqsanger.gz
	SRR22668007_1.fastq.gz	Fastqsanger.gz
	SRR22668007_2.fastq.gz	Fastqsanger.gz
	SRR22668008_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 31

Similar Datasets

Severe acute respiratory syndrome coronavirus 2

Project description:Deep mutational scanning of SARS-CoV-2 Spike HR1

| PRJNA826665 | ENA

SARS-CoV-2 pseudovirus strain:BA.2

Project description:SARS-CoV-2 BA.2 spike pseudovirus-based deep mutational scanning

| PRJNA1035933 | ENA

Severe acute respiratory syndrome coronavirus 2

Project description:Deep mutational scanning of SARS-CoV-2 Spike N-terminal domain (NTD)

| PRJNA792013 | ENA

Nanomolar inhibition of SARS-CoV-2 infection by N-terminally extended HR2 peptides

Project description:Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) challenge currently available COVID-19 vaccines and monoclonal antibody therapies through changes of epitopes on the receptor binding domain of the viral spike glycoprotein (S). Hence, there is a specific urgent need for alternative antivirals that target processes less likely to be affected by mutation, such as the membrane fusion step of viral entry into the host cell. One such antiviral class includes peptide inhibitors which block formation of the HR1HR2 six-helix bundle of the SARS-CoV-2 spike protein and thus interfere with viral membrane fusion; HR2 derived peptides are validated inhibitors of this process. Here, we identify a short N-terminal region that, when appended to the helical region of an HR2 peptide from previous studies, leads to potent inhibition of fusion. The extended peptide shows an ~100-fold increase in efficacy compared with the previously used 36-amino-acid version of HR2, effectively achieving single-digit nanomolar inhibition of SARS-CoV-2 in cell-based fusion, VSV-SARS-CoV-2 chimera, and authentic SARS-CoV-2 infection assays. The peptide also strongly inhibits all major SARS-CoV-2 variants to date. Structural studies of the HR1HR2 bundle reveal the formation of an extended, stabilized N-terminus that interacts with the HR2 triple helix, further stabilizing the HR1HR2 bundle. Together, these results suggest that regions outside the previously studied HR2 helical region may offer new opportunities for potent peptide-derived therapeutics for SARS-CoV-2 and its variants.

2022-09-21 | GSE203229 | GEO

Project description:SARS-CoV-2 spike phage deep mutational scanning study of Kenyan infants and mothers

| PRJNA872509 | ENA

Project description:Deep mutational scanning of SARS-CoV-2 3CL protease

| PRJNA813935 | ENA

Project description:SARS-CoV-2 spike phage deep mutational scanning to map binding residues of monoclonal antibodies

| PRJNA1122188 | ENA

Project description:Deep mutational scanning of human ACE2's interaction with the SARS-Cov-2 spike protein

| PRJNA720933 | ENA

Severe acute respiratory syndrome coronavirus 2 strain:Delta

Project description:A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 Delta spike

| PRJNA889020 | ENA

Project description:SARS-CoV-2 spike phage deep mutational scanning to map binding residues of monoclonal antibodies

| PRJNA1130943 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data